scholarly article | Q13442814 |
P50 | author | Annet Kirabo | Q91272577 |
P2093 | author name string | Sean S Davies | |
Kala B Dixon | |||
P2860 | cites work | Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing | Q24307979 |
Toll-like receptor signalling | Q24570126 | ||
Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis | Q24629328 | ||
The relationship between dose of vitamin E and suppression of oxidative stress in humans | Q24680423 | ||
Insights into rheumatoid arthritis derived from the Sa immune system | Q24805044 | ||
Inflammation, immunity, and hypertensive end-organ damage | Q26827525 | ||
Immune activation caused by vascular oxidation promotes fibrosis and hypertension | Q27332212 | ||
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood | Q28138201 | ||
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 | Q28585931 | ||
A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. | Q29035699 | ||
Recognition of microorganisms and activation of the immune response | Q29617903 | ||
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). | Q31956512 | ||
Decrease in circulating myeloid dendritic cell precursors in coronary artery disease | Q33248542 | ||
Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease | Q33276712 | ||
Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease | Q33371048 | ||
Transient decrease in circulating dendritic cell precursors after acute stroke: potential recruitment into the brain | Q33464564 | ||
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 | ||
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q33960122 | ||
Cross-presentation in viral immunity and self-tolerance. | Q34119651 | ||
Cross-presentation, dendritic cells, tolerance and immunity | Q34178099 | ||
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials | Q34206974 | ||
Recruitment of circulating dendritic cell precursors into the infarcted myocardium and pro-inflammatory response in acute myocardial infarction | Q34228722 | ||
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells | Q34331407 | ||
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial | Q34403303 | ||
Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction | Q34429790 | ||
DC isoketal-modified proteins activate T cells and promote hypertension. | Q34454645 | ||
Feasibility of treating prehypertension with an angiotensin-receptor blocker | Q34502178 | ||
23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients | Q34556902 | ||
Mouse and human dendritic cell subtypes | Q34576401 | ||
Emergence of dendritic cells in the myocardium after acute myocardial infarction - implications for inflammatory myocardial damage | Q34722498 | ||
Circulating dendritic cell precursors in chronic kidney disease: a cross-sectional study | Q35064431 | ||
Redox-regulated suppression of splenic T-lymphocyte activation in a model of sympathoexcitation. | Q35175596 | ||
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation | Q35183974 | ||
Lymphocyte responses exacerbate angiotensin II-dependent hypertension | Q35576468 | ||
Integrative network analysis reveals molecular mechanisms of blood pressure regulation | Q35577186 | ||
Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity | Q35613674 | ||
Immunosuppressive treatment protects against angiotensin II-induced renal damage | Q35747734 | ||
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension | Q36239599 | ||
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
The toll of the gridiron: damage-associated molecular patterns and hypertension in American football | Q36385414 | ||
Toll-like Receptors in the Vascular System: Sensing the Dangers Within | Q36453194 | ||
Presentation of phagocytosed antigens by MHC class I and II. | Q36514286 | ||
Interleukin-1 Receptor Activation Potentiates Salt Reabsorption in Angiotensin II-Induced Hypertension via the NKCC2 Co-transporter in the Nephron. | Q36568185 | ||
Nod-like proteins in immunity, inflammation and disease | Q36655897 | ||
The CD4⁺ T-cell help signal is transmitted from APC to CD8⁺ T-cells via CD27-CD70 interactions | Q36712124 | ||
CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli | Q36803422 | ||
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity. | Q36919720 | ||
The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats | Q36985976 | ||
Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension | Q36989555 | ||
The microbial and danger signals that activate Nod-like receptors | Q37248127 | ||
Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via α-adrenergic receptors | Q37346056 | ||
Innate immunity to virus infection. | Q37361448 | ||
Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. | Q37575843 | ||
Potential role of Toll-like receptors in programming of vascular dysfunction | Q37731715 | ||
Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats | Q37731722 | ||
Role of CD27/CD70 pathway of activation in immunity and tolerance | Q37779170 | ||
The many roles of NOX2 NADPH oxidase-derived ROS in immunity | Q37783925 | ||
Dendritic cells in cardiovascular diseases: epiphenomenon, contributor, or therapeutic opportunity | Q38171784 | ||
Human dendritic cell subsets and function in health and disease | Q38561058 | ||
Sympathetic-mediated activation versus suppression of the immune system: consequences for hypertension. | Q38717874 | ||
Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation | Q39786697 | ||
Characterization of human blood dendritic cell subsets | Q40625943 | ||
Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function | Q40735583 | ||
Expanding antigen-specific regulatory networks to treat autoimmunity | Q40787726 | ||
Role of dendritic cells in cardiovascular diseases | Q41332123 | ||
Oligoclonal CD8+ T cells play a critical role in the development of hypertension | Q41860638 | ||
Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension | Q42703902 | ||
Levuglandins: isolation, characterization, and total synthesis of new secoprostanoid products from prostaglandin endoperoxides | Q43935920 | ||
Control of hypertension among adults--National Health and Nutrition Examination Survey, United States, 2005-2008. | Q44721268 | ||
Global Noncommunicable Diseases — Where Worlds Meet | Q47358633 | ||
Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy | Q48547775 | ||
Ralph Steinman | Q48765071 | ||
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets | Q56987951 | ||
Levuglandin E2 crosslinks proteins | Q69685615 | ||
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation | Q73084676 | ||
Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 | ||
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes | Q73371663 | ||
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails | Q73413378 | ||
Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease | Q74376293 | ||
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts | Q77388164 | ||
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha | Q79372327 | ||
Can vitamin E prevent cardiovascular events and cancer? | Q81267327 | ||
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque | Q81444765 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | H368-H374 | |
P577 | publication date | 2016-12-16 | |
P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
P1476 | title | Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension | |
P478 | volume | 312 |